Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC). The studies are quite heterogenous regarding study size and populations, and a synopsis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaofeng, Liu, Yiqian, Røe, Oluf Dimitri, Qian, Yingying, Guo, Renhua, Zhu, Lingjun, Yin, Yongmei, Shu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605444/
https://www.ncbi.nlm.nih.gov/pubmed/23555654
http://dx.doi.org/10.1371/journal.pone.0059314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605444/
https://www.ncbi.nlm.nih.gov/pubmed/23555654
http://dx.doi.org/10.1371/journal.pone.0059314

Ejemplares similares